Login

Healthcare

00:00:00
Cell & Gene Exchange, May 2017: BrainStorm Cell Therapeutics - Chaim Lebovits, CEO, Brainstorm Cell Therapeutics Inc
00:00:00
Dr. Gregory Bayer, CEO, Brain Resource
00:00:00
Jesper Söderqvist, CEO, Boule Diagnostics
00:00:00
BOT Investor Webinar | 26 September 2023 - Vince Ippolito Executive Chairman, Botanix Pharmaceuticals Ltd
00:00:00
Thomas Lienard, CEO, Bone Therapeutics
00:00:00
Biotec Pharmacon presentation - Christian Jorgensen, CEO, Biotec Pharmacon A
00:00:00
René C. Goehrum President & Chief Executive Officer, Biosyent Inc
00:00:00
Petter Bäckgren, CEO, Bioservo Technologies
00:00:00
Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:00:00
BioPorto optimistic over FDA clearance for its NGAL kidney diagnostic test for use on children - Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:00:00
BioPorto discusses 'fantastic first half of the year' driven by antibodies and RUO NGAL Test sales - Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:00:00
BioPorto CEO explains why he's expecting 2021 to be a 'pivotal year - Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:00:00
BioPorto discusses 'fantastic first half of the year' driven by antibodies and RUO NGAL Test sales - Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:00:00
Biophytis sees positive data from PHASE 2-3 COVA CLINICAL STUDY of Sarconeos - Stanislas Veillet , CEO, Biophytis
00:00:00
BioInvents's CEO Martin Welschof presents the company - Martin Welschof Chief Executive Officer, BioInvent International
00:00:00
Bioasis Technologies forms 'exciting' licensing agreement with Chiesi Global Rare Diseases - Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE -Executive Chair, biOasis Technologies Inc

© 2026 Nehu